Articles tagged with Bacterial Infections
A new study found that living near livestock may increase the risk of acquiring MRSA, with regional density of livestock being an important risk factor for nasal carriage. The study suggests that community members in animal-dense regions who are otherwise unaffiliated with livestock farming are at higher risk.
Researchers discovered that immune cells use vitamin B products to recognize bacterial infections, triggering an immune response. This finding opens up potential targets for improving treatments or developing a vaccine for tuberculosis.
A computer simulation study found that hospitals working together and coordinating their infection control procedures can significantly reduce the prevalence of MRSA infections. By implementing contact isolation protocols, hospitals can not only improve their own infection control but also benefit neighboring hospitals.
A new class of treatment has been identified against methicillin-resistant Staphylococcus aureus (MRSA), a 'superbug' responsible for difficult-to-treat illnesses. The compound, developed from an anti-cancer agent, shows promise in treating MRSA-infected mice and has the potential to combat drug-resistant tuberculosis.
Researchers found that T2R38 is expressed in upper respiratory tract cells and activated by bacteria, correlating with increased susceptibility to sinus infections. Genetic variation in the T2R38 gene contributes to individual differences in respiratory infection risk.
Researchers have made progress in tackling C. difficile infections using mouse models and human patients, with potential treatments including an oral medication and genetic mutation detection. The studies found that administering an oral supplement can prevent CDI, while detecting a specific gene mutation may predict recurrent infections.
Researchers have developed a new class of antibiotics that disarm pathogens instead of killing them, effectively treating antibiotic-resistant infections. By blocking the synthesis of endotoxin, a toxic product shed by bacteria, these antibiotics prevent inflammation and protect against potentially lethal infections.
The study found significant variation in adoption of screening and infection control interventions aimed at MDROs and C. difficile, with some hospitals screening for all admissions and others infrequently.
Researchers describe experiments exploring multi-drug tolerance, a phenomenon that allows bacteria to outwit antibiotics. By analyzing HipA protein's structure and biochemical components, they gained insight into how this mechanism enables bacterial dormancy.
Scientists have isolated and studied 11 viruses that can infect and kill the acne-causing bacterium P. acnes, potentially paving the way for topical therapies. The study found that these phages share a high degree of similarity in their DNA, making it less likely to develop resistance to phage-based antimicrobial therapy.
Researchers at UC Berkeley discovered that corneal epithelial cells express small antimicrobial peptides to defend against bacterial infection. These peptides prevent bacteria from binding to epithelial cells and are crucial in protecting the eye against infections, as evidenced by mice lacking cytokeratin 6A being more susceptible.
Researchers at MU developed a technique using bacteriophages to selectively kill harmful bacteria in water treatment facilities. This method could save taxpayers money by reducing cleaning costs and has potential applications against deadly antibiotic-resistant bacteria.
A new X-ray study reveals that persister cells are regulated by toxins produced by the bacteria themselves, allowing them to enter a dormant state. This understanding can lead to the development of treatments that block toxin function and production, potentially improving outcomes in life-threatening diseases.
Scientists have identified a substance that primes the body's immune system to fight infections, including flu, in a nasal spray. The synthetic form of Pam2Cys has shown promise in activating the innate immune system without replacing a normal response.
A new model developed by Weizmann Institute mathematicians and physicians proposes a more individualized approach to chemotherapy by considering not only the quantity but also the quality of blood cells. This could lead to better precautions for high-risk patients and spare unnecessary preventive treatments for those at low risk.
Researchers at Case Western Reserve University have developed novel antivirulence drugs that block toxin production in bacteria, rendering them harmless. The discovery has the potential to combat antibiotic-resistant infections like MRSA and strep.
New guidelines from Infectious Diseases Society of America recommend penicillin or amoxicillin for confirmed strep throat infections. The guidelines also advise against tonsillectomy for children with recurrent strep throat unless in specific cases.
Researchers at Boston Children's Hospital have created a model to study sepsis in newborns, identifying diagnostic markers and potential treatments. The model has shown that even at the earliest hours of life, newborns can mount a robust inflammatory response to bacterial challenge.
A recent study in Rochester, NY, documents 19 cases of infected tattoos caused by a type of bacteria often found in tap water. Premixed gray ink is the suspected source of the infection, which was treated with antibiotics and resolved in most patients.
Researchers at the University of Nottingham have developed a novel antimicrobial catheter that can kill most urinary bacteria, including Proteus bacteria, for up to twelve weeks. This innovation has significant advantages over existing solutions, offering a solution to recurrent infections in long-term catheter users.
Researchers at Tel Aviv University have developed a treatment for coral infected with White Plague disease, a deadly bacterium that causes 9% of Favia favus corals to die. The treatment uses viruses that infect bacteria, providing a breakthrough in developing regionalized treatments.
New research from the Trudeau Institute reveals a negative feedback loop regulating immune response to bacteria, preventing tissue damage while controlling bacterial growth. The study's findings have potential applications in improving prevention and treatment strategies for bacterial infections.
Researchers at the University of Iowa have developed a mouse model of Fukuyama's muscular dystrophy, providing insight into disease development. Vitamin B3 has also been shown to aid in fighting staph infections by increasing C/EBPε expression in mice. Meanwhile, a new class of cerebrospinal fluid-based biomarkers for neurodegenerative...
Researchers at the University of Delaware found that beneficial bacteria in soil can signal plants' stomata to close, preventing disease infection. This discovery highlights the potential for probiotics to bolster plant immunity naturally.
A new study suggests that nicotinamide, a form of vitamin B3, can increase the ability of immune cells to kill staph bacteria by 1,000 times. This could offer a new tool in the fight against 'superbugs' and potentially reduce dependence on antibiotics.
Researchers develop smart catheter that senses infection and releases nitric oxide to stop bacterial growth, reducing healthcare-associated infections. The device has shown promising results in lab experiments, with the ability to extend NO release for up to weeks.
A deadly outbreak of antibiotic-resistant bacteria at NIH's Clinical Center was quelled through collaboration with genomic experts. Genome sequencing revealed the outbreak had a single source, and targeted interventions stopped its spread.
Researchers found drug-resistant Staphylococcus aureus in 36 chimpanzees (58% of tested), with nearly 10% showing multi-drug resistance. The risk of acquiring novel pathogens from humans poses a significant threat to wild apes, echoing worst-case scenarios in U.S. hospitals.
Researchers at University of Wisconsin-Madison have identified small molecule chemicals that can disrupt quorum sensing in Acinetobacter baumanni, a pathogenic bacterium responsible for deadly hospital-acquired infections. The compounds may potentially be used to limit the virulence of the bacteria and prevent biofilm formation.
A groundbreaking clinical trial is underway to test the safety and efficacy of fecal transplantation as a treatment for relapsing C. difficile infection. The study aims to demonstrate that fecal transplant is a viable, safe, and curative option for patients suffering from recurring C. difficle.
Cefazolin outperforms vancomycin in preventing hospitalizations and deaths from specific bloodstream infections, a study reveals. The antibiotic was found to be 48% more effective at preventing sepsis.
Researchers demonstrate that bacteria can form antibiotic-resistant clumps in a short time, even in a flowing liquid such as the blood, leading to severe infections. These clumps persist even when two different types of antibiotics are added, suggesting that sticking together protects the floating bacteria from the drugs' effects.
Scientists develop substances targeting bacteria virulence factors to prevent UTI development and emergence of resistant microbes. A low dose reduced bacteria in the bladder by almost 10,000 times.
A study published in CMAJ found that fluoroquinolone antibiotics, particularly moxifloxacin and levofloxacin, are linked to a higher risk of acute liver injury in older adults. The research suggests these drugs should be subject to regulatory warnings due to their potential harm.
Scientists at the University of Nottingham have developed new polymers resistant to bacterial attachment, reducing biofilm formation and infection rates. The breakthrough could lead to a significant reduction in hospital infections and medical device failures, with initial results showing up to 96.7% reduction in bacteria.
A pediatric hospital implemented a prospective-audit-with-feedback antibiotic stewardship program, resulting in a significant decrease in antibiotic usage - up to 37% in early months and 13% at the end of the observation. The study showed a notable reduction in broad-spectrum antibiotics, aligning with CDC recommendations.
Scientists have developed a new method to study how the immune system interacts with bacteria during chronic infections. The method uses 5 mm silicone tubes and combines light microscopy and electron microscopy to visualize the interaction between white blood cells and bacteria.
Researchers used 99mTc-HMPAO-WBC SPECT/CT to diagnose infectious endocarditis in hard-to-diagnose cases, achieving high sensitivity and specificity. The test detected septic embolism in 41% of patients, aiding physicians in diagnosis and treatment.
A team of researchers at Michigan State University has identified the secret to the deadly 2011 E. coli outbreak in Germany, attributing its lethality to biofilm formation. By targeting this mechanism, the researchers aim to potentially tame the killer bacteria.
A 500-year-old Incan mummy was found to have a bacterial lung infection at the time of death, according to a new study published in PLOS ONE. The researchers used proteomics to analyze immune system response from degraded samples and found that one mummy had a protein profile similar to those with chronic respiratory infections.
Scientists at Monash University have deciphered the atomic structure of PlyC, a powerful anti-bacterial lysin that kills bacteria causing infections from sore throats to pneumonia. PlyC's unique 'saucer' shape and eight docking sites make it 100 times more efficient than other lysins at killing certain bacteria.
A MCG student has received a $5,000 research fellowship to investigate risk factors for bacteremia in dialysis patients. The study aims to identify potential associations with diabetes, dialysis catheter use, and other factors.
A new study published in PLOS Medicine found that public reporting of hospital-acquired infection data led to a significant reduction in C. difficile cases. The study showed a 26% decrease in C. difficile infections after mandatory hospital reporting was introduced in Ontario, Canada.
A study published in Nature reveals that the HVEM molecule plays a critical role in protecting against bacterial infections, including E. coli and pneumococcus, by acting as a border guard to signal the immune system to respond. The discovery provides a potential new therapeutic target for preventing and treating bacterial infections.
Scientists studied Agrobacterium tumefaciens, a rod-shaped soil bacterium responsible for crown gall disease in plants. They discovered that the bacterium maintains its linear chromosome through an enzyme called TelA, which forms hairpin loops to protect it.
A new study published in the Canadian Medical Association Journal found that uncircumcised boys are at a higher risk of urinary tract infections. The researchers did not find a significant association between the degree of urethral visibility and infection risk.
Researchers at UCLA are conducting a clinical trial to investigate the impact of copper surfaces on reducing hospital-acquired infections. The study aims to determine if lowering bacteria levels on hospital surfaces results in reduced infection rates, better patient outcomes, and lower costs.
A study reviewed medical literature on cranberry products and found a reduced risk of urinary tract infections in individuals who consume these products regularly. The study suggests that cranberry-containing products may be effective in preventing UTIs in specific groups, such as women with recurrent UTIs and children.
Researchers at Keck School of Medicine of USC identify TLR1 protein as critical component driving mucosal immune response against bacteria like Salmonella and E. coli, which cause food poisoning and gastrointestinal infections. The discovery may lead to the development of more effective oral vaccines.
Researchers discovered that E. coli uses yersiniabactin to steal copper from host cells, allowing the bacteria to grow and reproduce. This finding could lead to new treatments for serious urinary tract infections. By blocking this thievery with a drug, patients' chances of fighting off infections may significantly improve.
Researchers discovered rare variations in the DCTN4 gene among cystic fibrosis patients with early, chronic airway infections. The study suggests that exome sequencing can identify genetic factors behind complex traits like obesity and heart disease.
A study by University of Iowa researchers found that cystic fibrosis makes airways more acidic, reducing bacterial killing. Making the airway liquid less acidic with baking soda restores normal bacterial killing levels.
Researchers discovered that mice without NLRP6 receptor protein are better protected against bacterial infections and can more easily remove bacteria. This finding opens up a new therapeutic track for treating bacterial infections beyond antibiotics.
A new study led by St. Jude Children's Research Hospital identified an innate immune system component that suppresses inflammation, which in turn dampens the immune response to infections. The findings suggest that targeting this protein could block bacterial infection and offer a completely new approach to fighting infections.
Biochemist Alejandro Heuck maps molecular structure of needle-like tool used by bacteria to drill holes in mammalian cell walls. Researchers aim to identify new targets for developing drugs and treatments against diseases caused by bubonic plague, dysentery, food poisoning, and sepsis.
Researchers at Caltech have developed a method to measure the rate of DNA transfer from viruses to bacteria. They found that the amount of genetic material within the bacterial cells determines how quickly the bacteriophage's DNA is transferred, not the pressure in the virus itself.
Researchers found that inhibiting a key immune response early on can shorten TB treatment time and prevent relapse. In a study, mice treated with standard TB medication plus a TNF-alpha inhibitor had a significantly lower bacterial burden than those receiving only the standard treatment.
A study by UCSF found that bacterial vaginosis increases female-to-male HIV transmission risk threefold. Women with the condition are more likely to transmit HIV to their male partners, highlighting the need for better understanding and treatment of the disorder.
A novel diagnostic test has been developed to accurately detect Group B Streptococcal infection in babies, allowing for quicker treatment and potentially reducing mortality rates. The test detects the presence of a specific gene in the bacteria, which is an important disease-causing factor.
A survey of 3,800 home healthcare providers found that many agencies lack written policies on handling infection control for antibiotic-resistant infections. The study highlights the need for simple and quick actions like hand washing, vaccinations, and patient isolation to decrease infections in home care settings.